SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LoLoLoLita who wrote (4671)1/16/1998 1:03:00 PM
From: Zebra 365   of 23519
 
I'm loving this. I think that for the fist time since October, all things considered, there are more potential upside surprises than downside. Maybe Wall Street doesn't like surprises, but short sellers absolutely hate them.

I think the realization that there will be a product overhang, with the potential for sudden revenues whenever MCA approves, would be enough for me to close a short position, on a stock with a P/E of 10.

The Phoenix is about to arise from the ashes!!

(i hope)

Zebra

PS CS First Boston rated VVUS a Buy at 38 and a Hold at 24. These are the same guys who lost about 40 million in the Peregrine bank failure. Not having a good year so far.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News